Back to Search
Start Over
Correction: MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.
- Source :
-
Oncogene [Oncogene] 2023 Dec; Vol. 42 (50), pp. 3719. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 1476-5594
- Volume :
- 42
- Issue :
- 50
- Database :
- MEDLINE
- Journal :
- Oncogene
- Accession number :
- 37978227
- Full Text :
- https://doi.org/10.1038/s41388-023-02870-9